Sale!

SACURISE 100 TAB

Original price was: ₹350.00.Current price is: ₹315.00.

Sacurise 100 Tablet is a pharmaceutical product containing Valsartan and Sacubitril, used for the treatment of heart failure or reduced ejection fraction.

SKU: 70428 Categories: ,

Description

Sacurise 100 Tablet is a pharmaceutical product that contains a composition of Valsartan and Sacubitril. It is primarily used for the treatment of heart failure and reduced ejection fraction.

This medication is prescribed to patients who have chronic heart failure to improve their symptoms and reduce the risk of hospitalization. It is especially effective for patients who cannot tolerate angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs).

The mechanism of action of Sacurise 100 Tablet involves the combination of Valsartan and Sacubitril. Valsartan is an ARB that works by blocking the action of angiotensin II, a substance that causes blood vessels to narrow and increase blood pressure. On the other hand, Sacubitril inhibits the enzyme neprilysin, which breaks down substances that promote blood vessel relaxation and sodium excretion. By inhibiting neprilysin, Sacubitril increases the levels of these substances, leading to vasodilation and reduced sodium retention.

This combination of Valsartan and Sacubitril has been clinically proven to be highly effective in reducing the risk of heart failure progression and hospitalization in patients with heart failure and reduced ejection fraction. It has shown superior results compared to traditional heart failure treatments.

In conclusion, Sacurise 100 Tablet is a crucial medication for the treatment of heart failure and reduced ejection fraction. With its unique composition of Valsartan and Sacubitril, it provides significant benefits in improving symptoms, reducing hospitalization risk, and ultimately enhancing the quality of life for patients with this condition. It is important to follow the prescribed dosage and consult a healthcare professional for personalized advice and monitoring.

Additional information

Weight 15.0 g
Marketed by

Composition

Dosage form

TABLET

Prescription

REQUIRED

Therapeutic use

NORMAL